Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Gene expression profiles in cells transformed by overexpression of the IGF-I receptor

Abstract

To identify genes associated with insulin-like growth factor-I receptor (IGF-IR)-mediated cellular transformation, we isolated genes that are differentially expressed in R cells (derived from the IGF-IR knockout mouse) and R+ cells (R cells that overexpress the IGF-IR). From these, 45 genes of known function were expressed at higher levels in R+ cells and 22 were expressed at higher levels in R cells. Differential expression was confirmed by Northern blot analysis of R+ and R cells. Genes expressed more abundantly in R+ cells are associated with (1) tumour growth and metastasis including, βigH3, mts1, igfbp5 protease, and mystique; (2) cell division, including cyclin A1 and cdk1; (3) signal transduction, including pkcδbp and lmw-ptp; and (4) metabolism including ATPase H+ transporter and ferritin. In MCF-7 cells IGF-I induced expression of two genes, lasp-1 and mystique, which could contribute to metastasis. Lasp-1 expression required activity of the PI3-kinase signalling pathway. Mystique was highly expressed in metastatic but not in androgen-dependent prostate cancer cell lines and Mystique overexpression in MCF-7 cells promoted cell migration and invasion. We conclude that genes identified in this screen may mediate IGF-IR function in cancer progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  • Ambartsumian NS, Grigorian MS, Larsen IF, Karlstrom O, Sidenius N, Rygaard J, Georgiev G and Lukanidin E . (1996). Oncogene, 13, 1621–1630.

  • Bandara LR, Lam EW, Sorensen TS, Zamanian M, Girling R and La Thangue NB . (1994). EMBO J., 13, 3104–3114.

  • Brodt P, Fallavollita L, Khatib AM, Samani AA and Zhang D . (2001). J. Biol. Chem., 276, 33608–33615.

  • Brodt P, Samani A and Navab R . (2000). Biochem. Pharmacol., 60, 1101–1107.

  • Burfeind P, Chernicky CL, Rininsland F and Ilan J . (1996). Proc. Natl. Acad. Sci. USA, 93, 7263–7268.

  • Clemmons DR, Dehoff ML, Busby WH, Bayne ML and Cascieri MA . (1992). Endocrinology, 131, 890–895.

  • Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED and Siebert PD . (1996). Proc. Natl. Acad. Sci. USA, 93, 6025–6030.

  • Dunn SE, Ehrlich M, Sharp NJ, Reiss K, Solomon G, Hawkins R, Baserga R and Barrett JC . (1998). Cancer Res., 58, 3353–3361.

  • Dupont J, Khan J, Qu BH, Metzler P, Helman L and LeRoith D . (2001). Endocrinology, 142, 4969–4975.

  • Ebralidze A, Tulchinsky E, Grigorian M, Afanasyeva A, Senin V, Revazova E and Lukanidin E . (1989). Genes Dev., 3, 1086–1093.

  • Fiaschi T, Chiarugi P, Buricchi F, Giannoni E, Taddei ML, Talini D, Cozzi G, Zecchi-Orlandini S, Raugei G and Ramponi G . (2001). J. Biol. Chem., 10, 10.

  • Flier JS, Usher P and Moses AC . (1986). Proc. Natl. Acad. Sci. USA, 83, 664–668.

  • Harrington EA, Bennett MR, Fanidi A and Evan GI . (1994). EMBO J., 13, 3286–3295.

  • Hellawell GO, Turner GD, Davies DR, Poulsom R, Brewster SF and Macaulay VM . (2002). Cancer Res., 62, 2942–2950.

  • Izumi Y, Hirai S, Tamai Y, Fujise-Matsuoka A, Nishimura Y and Ohno S . (1997). J. Biol. Chem., 272, 7381–7389.

  • Kaleko M, Rutter WJ and Miller AD . (1990). Mol. Cell. Biol., 10, 464–473.

  • Lee CT, Wu S, Gabrilovich D, Chen H, Nadaf-Rahrov S, Ciernik IF and Carbone DP . (1996). Cancer Res., 56, 3038–3041.

  • LeRoith D and Helman L . (2004). Cancer Cell, 5, 201–202.

  • Lin YH, Park ZY, Lin D, Brahmbhatt AA, Rio MC, Yates III JR and Klemke RL . (2004). J. Cell Biol., 165, 421–432.

  • Liu T-J, Lai H-C, Wu W, Chinn S and Wang P . (2000). Circ. Res., 88, 1231–1238.

  • Long L, Navab R and Brodt P . (1998). Cancer Res., 58, 3243–3247.

  • Long L, Rubin R, Baserga R and Brodt P . (1995). Cancer Res., 55, 1006–1009.

  • Lopez T and Hanahan D . (2002). Cancer Cell, 1, 339–353.

  • Loughran G, Healy N, Kiely PA, Huigsloot M, Kedersha NL and O'Connor R . (2005). Mol. Biol. Cell, 16, 1811–1822.

  • Mauro L, Bartucci M, Morelli C, Ando S and Surmacz E . (2001). J. Biol. Chem., 276, 39892–39897.

  • Miele C, Rochford JJ, Filippa N, Giorgetti-Peraldi S and Van Obberghen E . (2000). J. Biol. Chem., 275, 21695–21702.

  • Mulligan C, Rochford J, Denyer G, Stephens R, Yeo G, Freeman T, Siddle K and O'Rahilly S . (2002). J. Biol. Chem., 277, 42480–42487.

  • O'Connor R, Kauffmann-Zeh A, Liu Y, Lehar S, Evan GI, Baserga R and Blattler WA . (1997). Mol. Cell. Biol., 17, 427–435.

  • Pind SN, Nuoffer C, McCaffery JM, Plutner H, Davidson HW, Farquhar MG and Balch WE . (1994). J. Cell Biol., 125, 239–252.

  • Playford MP, Bicknell D, Bodmer WF and Macaulay VM . (2000). Proc. Natl. Acad. Sci. USA, 97, 12103–12108.

  • Rodriguez-Tarduchy G, Collins MK, Garcia I and Lopez-Rivas A . (1992). J. Immunol., 149, 535–540.

  • Schafer BW and Heizmann CW . (1996). Trends Biochem. Sci., 21, 134–140.

  • Sell C, Dumenil G, Deveaud C, Miura M, Coppola D, DeAngelis T, Rubin R, Efstratiadis A and Baserga R . (1994). Mol. Cell. Biol., 14, 3604–3612.

  • Sell C, Rubini M, Rubin R, Liu JP, Efstratiadis A and Baserga R . (1993). Proc. Natl. Acad. Sci. USA, 90, 11217–11221.

  • Skonier J, Neubauer M, Madisen L, Bennett K, Plowman GD and Purchio AF . (1992). DNA Cell Biol., 11, 511–522.

  • Surmacz E, Guvakova MA, Nolan MK, Nicosia RF and Sciacca L . (1998). Breast Cancer Res. Treat., 47, 255–267.

  • Surmacz E, Nugent P, Pietrzkowski Z and Baserga R . (1992). Exp. Cell Res., 199, 275–278.

  • Tomasetto C, Moog-Lutz C, Regnier CH, Schreiber V, Basset P and Rio MC . (1995a). FEBS Lett., 373, 245–249.

  • Tomasetto C, Regnier C, Moog-Lutz C, Mattei MG, Chenard MP, Lidereau R, Basset P and Rio MC . (1995b). Genomics, 28, 367–376.

  • Tsujimoto H, Nishizuka S, Redpath JL and Stanbridge EJ . (1999). Mol. Carcinog., 26, 298–304.

  • Valentinis B, Romano G, Peruzzi F, Morrione A, Prisco M, Soddu S, Cristofanelli B, Sacchi A and Baserga R . (1999). J. Biol. Chem., 274, 12423–12430.

  • Varnum BC, Ma QF, Chi TH, Fletcher B and Herschman HR . (1991). Mol. Cell. Biol., 11, 1754–1758.

  • Zimmer DB, Cornwall EH, Landar A and Song W . (1995). Brain Res. Bull., 37, 417–429.

Download references

Acknowledgements

This work was funded by Tanaud Ireland Inc., Higher Education Authority of Ireland, Cancer Research Ireland, and Science Foundation Ireland. We are grateful to Kurt Tidmore for preparing the illustrations.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rosemary O'Connor.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Loughran, G., Huigsloot, M., Kiely, P. et al. Gene expression profiles in cells transformed by overexpression of the IGF-I receptor. Oncogene 24, 6185–6193 (2005). https://doi.org/10.1038/sj.onc.1208772

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208772

Keywords

Search

Quick links